Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: yahoo finance guy doesn't get it...

We won't see any transparancy until the issue is decided in court. It is rather obvious that TPL is taking no chances with any PR slip ups or any type of liability in relation to PR's until the trial is over. Could be the reason that they chose the Agoracom route. Using the message board to get the Company message out leaves them, if they are not involved, with no liability and no accountability to TPL I'll be curious to see how they use the 5 mil backberries, but I am not holding my breath. I'd be surprized if they use anything but the message board. I still don't think we will hear anything of significance from the company and  certainly not until it is screened by TPL.

 

 

Share
New Message
Please login to post a reply